Quality of Life After an Ambulatory Reconstruction of the NCT00285987

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Details — Status: Withdrawn

Study to compare the quality of life after reconstruction of the cruciate ligament in hospitalized versus day-clinic patient

Recruitment information / eligibility
Status	Withdrawn
Enrollment	0
Est. completion date
Est. primary completion date
Accepts healthy volunteers	No
Gender	All
Age group	18 Years to 50 Years
Eligibility	Inclusion Criteria: - rupture of the cruciate ligament Exclusion Criteria: -

Procedure:
• Reconstruction of the cruciate ligament

Locations
Country	Name	City	State
n/a

Sponsors *(1)*
Lead Sponsor	Collaborator
University Hospital, Ghent

Outcome
Type	Measure	Description	Time frame	Safety issue
Primary	Quality of life